A randomized, multi-center phase II trial to assess the fficacy of 5-Azacytidine added to standard primary therapie in elderly patients with newly diagnosed AML
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/07/2009 - 31/12/2011
Description
Keywords: AML
Funding identifier: 07GE053
Funder / funding scheme:
- Wirtschaft
Project management at the University of Münster
| Müller-Tidow, Carsten | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Applicants from the University of Münster
| Müller-Tidow, Carsten | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Research associates from the University of Münster
| Eveslage, Maria | Institute of Biostatistics and Clinical Research (IBKF) |
| Faldum, Andreas | Institute of Biostatistics and Clinical Research (IBKF) |
| Gerß, Joachim | Institute of Biostatistics and Clinical Research (IBKF) |